Avoid, Moderate Risk
Two GHRHs in the same regimen
Two GHRHs (e.g. CJC-1295 + Sermorelin, CJC-1295 + Tesamorelin)
Why this combination is flagged
Same receptor: competition at pituitary GHRH receptor; no additive benefit, reduced efficiency
Reported risk level
Moderate, per peptide research and practitioner literature catalogued on PeptideHelper.org.
Peptides involved
- CJC-1295, GHRH analog (no-DAC or DAC forms)
- Sermorelin, GHRH analog
- Tesamorelin, GHRH analog (FDA-approved)
Safer alternatives reported in literature
Pair a single GHRH (CJC-1295, Sermorelin, OR Tesamorelin) with a GHRP / ghrelin receptor agonist (Ipamorelin, GHRP-2/6, Hexarelin); the two classes act on complementary pathways and yield 2-3× GH release vs. either alone. The Gold Standard GH stack (CJC-1295 + Ipamorelin) is the most-cited example.
Reported research framing only. Not a clinical recommendation. Consult a qualified clinician before any human use.
Frequently asked questions
Why is Two GHRHs (e.g. CJC-1295 + Sermorelin, CJC-1295 + Tesamorelin) flagged as a combination to avoid?
Same receptor: competition at pituitary GHRH receptor; no additive benefit, reduced efficiency. Reported risk level in peptide research and practitioner literature: Moderate.
How serious is the concern with Two GHRHs (e.g. CJC-1295 + Sermorelin, CJC-1295 + Tesamorelin)?
PeptideHelper.org categorises this combination as Moderate risk based on published peptide research and practitioner literature. The mechanism: Same receptor: competition at pituitary GHRH receptor; no additive benefit, reduced efficiency.
What is a safer alternative to Two GHRHs (e.g. CJC-1295 + Sermorelin, CJC-1295 + Tesamorelin)?
Pair a single GHRH (CJC-1295, Sermorelin, OR Tesamorelin) with a GHRP / ghrelin receptor agonist (Ipamorelin, GHRP-2/6, Hexarelin); the two classes act on complementary pathways and yield 2-3× GH release vs. either alone. The Gold Standard GH stack (CJC-1295 + Ipamorelin) is the most-cited example.
Which peptides are involved in this combination?
Peptides referenced by this combination on PeptideHelper.org: CJC-1295, Sermorelin, Tesamorelin.
Open the PeptideHelper.org stack evaluator to model substitute combinations and check for class-level conflicts before any research use.
Loading interactive view…